Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Université Paris-Sud · Institut Gustave Roussy · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,382
total citations
- FWCI
- 94.87
- Percentile
- 100%
- References
- 40
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Abiraterone acetate
- Medicine
- Placebo
- Prednisone
- Prostate cancer
- Clinical endpoint
- Interim analysis
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.